← Browse by Condition
Medical Condition

proteinuric kidney disease

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06794996 Phase 2
Recruiting

Inaxaplin in Participants With Proteinuric APOL1 Mediated Kidney Disease With or Without Comorbidities

Enrollment
45 pts
Location
United States
Sponsor
Vertex Pharmaceuticals Incorpo...
View Trial →